Westlake Corp. (NYSE:WLK - Free Report) - Investment analysts at Zacks Research decreased their Q3 2026 earnings estimates for Westlake in a research note issued to investors on Tuesday, July 15th. Zacks Research analyst R. Department now expects that the specialty chemicals company will post earnings per share of $1.57 for the quarter, down from their prior estimate of $1.76. The consensus estimate for Westlake's current full-year earnings is $6.48 per share. Zacks Research also issued estimates for Westlake's Q4 2026 earnings at $0.38 EPS and Q1 2027 earnings at $0.92 EPS.
Westlake (NYSE:WLK - Get Free Report) last issued its quarterly earnings results on Friday, May 2nd. The specialty chemicals company reported ($0.31) EPS for the quarter, missing the consensus estimate of $0.70 by ($1.01). The firm had revenue of $2.85 billion during the quarter, compared to analysts' expectations of $2.97 billion. Westlake had a net margin of 3.23% and a return on equity of 4.19%. The firm's revenue was down 4.3% compared to the same quarter last year. During the same quarter last year, the company posted $1.34 EPS.
A number of other equities research analysts also recently issued reports on the stock. Royal Bank Of Canada increased their target price on shares of Westlake from $88.00 to $92.00 and gave the stock an "outperform" rating in a research report on Thursday, July 3rd. Wells Fargo & Company raised their target price on shares of Westlake from $76.00 to $90.00 and gave the company an "equal weight" rating in a research note on Monday. BMO Capital Markets set a $94.00 target price on shares of Westlake and gave the company a "market perform" rating in a research note on Tuesday, May 20th. Wall Street Zen lowered shares of Westlake from a "hold" rating to a "sell" rating in a research report on Friday, May 9th. Finally, Truist Financial decreased their target price on shares of Westlake from $117.00 to $92.00 and set a "buy" rating on the stock in a research report on Friday, May 30th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $93.77.
Check Out Our Latest Stock Report on Westlake
Westlake Stock Down 0.4%
Shares of NYSE:WLK opened at $81.39 on Thursday. Westlake has a 52 week low of $68.55 and a 52 week high of $153.34. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.86 and a current ratio of 2.63. The company has a market cap of $10.44 billion, a PE ratio of 27.31, a price-to-earnings-growth ratio of 9.72 and a beta of 0.91. The firm has a 50 day simple moving average of $77.39 and a 200 day simple moving average of $95.23.
Hedge Funds Weigh In On Westlake
Institutional investors have recently modified their holdings of the stock. Signaturefd LLC grew its position in shares of Westlake by 49.9% during the 2nd quarter. Signaturefd LLC now owns 640 shares of the specialty chemicals company's stock worth $49,000 after buying an additional 213 shares during the period. MFA Wealth Advisors LLC increased its stake in Westlake by 32.9% in the second quarter. MFA Wealth Advisors LLC now owns 2,886 shares of the specialty chemicals company's stock valued at $219,000 after purchasing an additional 715 shares in the last quarter. Farther Finance Advisors LLC increased its stake in Westlake by 1,840.4% in the second quarter. Farther Finance Advisors LLC now owns 1,921 shares of the specialty chemicals company's stock valued at $146,000 after purchasing an additional 1,822 shares in the last quarter. Wedge Capital Management L L P NC boosted its holdings in shares of Westlake by 39.9% in the second quarter. Wedge Capital Management L L P NC now owns 132,401 shares of the specialty chemicals company's stock valued at $10,053,000 after buying an additional 37,763 shares during the period. Finally, UMB Bank n.a. boosted its holdings in shares of Westlake by 107.0% in the second quarter. UMB Bank n.a. now owns 565 shares of the specialty chemicals company's stock valued at $43,000 after buying an additional 292 shares during the period. 28.40% of the stock is owned by institutional investors.
Westlake Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, June 5th. Shareholders of record on Tuesday, May 20th were paid a $0.525 dividend. This represents a $2.10 dividend on an annualized basis and a dividend yield of 2.58%. The ex-dividend date was Tuesday, May 20th. Westlake's dividend payout ratio is presently 70.47%.
Westlake Company Profile
(
Get Free Report)
Westlake Corporation engages in the manufacture and marketing of performance and essential materials, and housing and infrastructure products in the United States, Canada, Germany, China, Mexico, Brazil, France, Italy, Taiwan, and internationally. The company operates through two segments: Performance and Essential Materials and Housing and Infrastructure Products.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Westlake, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Westlake wasn't on the list.
While Westlake currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.